FDA approves weight loss drug Zepbound to treat obstructive sleep apnea – NPR

Business News

  1. FDA approves weight loss drug Zepbound to treat obstructive sleep apnea  NPR
  2. F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea  The New York Times
  3. FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea  ABC News
  4. FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity  Investors | Eli Lilly and Company
  5. The First Sleep Apnea Drug Is Here  TIME

Source: Business News

/by